Production (Stage)
Twist Bioscience Corporation
TWST
$28.26
$0.100.36%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -191.15M | -197.31M | -208.73M | -220.31M | -192.14M |
| Total Depreciation and Amortization | 25.14M | 27.04M | 28.83M | 32.38M | 32.57M |
| Total Amortization of Deferred Charges | 2.60M | 2.60M | 2.60M | 900.00K | 900.00K |
| Total Other Non-Cash Items | 105.28M | 98.43M | 97.79M | 100.57M | 55.72M |
| Change in Net Operating Assets | 2.02M | 6.69M | 15.41M | 16.99M | 16.45M |
| Cash from Operations | -56.11M | -62.55M | -64.09M | -69.48M | -86.51M |
| Capital Expenditure | -9.38M | -5.84M | -5.08M | -5.47M | -9.01M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 4.42M | -2.93M | 2.01M | 1.43M | 24.36M |
| Cash from Investing | -4.96M | -8.77M | -3.07M | -4.03M | 15.35M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 12.70M | 12.86M | 10.87M | 8.80M | 6.24M |
| Repurchase of Common Stock | -26.00K | -1.56M | -3.98M | -5.10M | -6.10M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 15.00M | 15.00M | -- | -- | -- |
| Cash from Financing | 27.68M | 26.31M | 6.89M | 3.71M | 136.00K |
| Foreign Exchange rate Adjustments | 126.00K | -43.00K | 126.00K | 5.00K | -317.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -33.27M | -45.06M | -60.15M | -69.80M | -71.35M |